Catherine Maari

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman et al. · The Lancet · 2020 · 452 citations · Full text

Allergy, Atopic Dermatitis, Medicine +9

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

Emma Guttman‐Yassky, Ana B. Pavel, Lisa Zhou et al. · Journal of Allergy and Clinical Immunology · 2019 · 210 citations · Full text

Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis

Helen He, Robert Bissonnette, Jianni Wu et al. · Journal of Allergy and Clinical Immunology · 2020 · 197 citations

Allergy, Detect Distinct Immune, Atopic Dermatitis +8

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 165 citations · Full text

A Prospective Randomized Trial Comparing the Efficacy and Adverse Effects of Four Recognized Treatments of Molluscum Contagiosum in Children

Dominique Hanna, Afshin Hatami, Julie Powell et al. · Pediatric Dermatology · 2006 · 133 citations